Non-alcoholic fatty liver disease and liver transplantation
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Cirrhosis secondary to non-alcoholic steatohepatitis (NASH) is a common indication for liver transplant. In comparison to other cirrhotic patients, patients with NASH cirrhosis are more likely to be older and have the metabolic syndrome. Pre-transplant, patients require careful evaluation of cardiovascular risk. As the incidence of non-alcoholic fatty liver disease (NAFLD) is rising, a greater proportion of donor grafts have steatosis greater than 30%, which is associated with poor outcomes. Grafts with steatosis greater than 60% are unsuitable for transplant. Overall, post-transplant survival outcomes for patients with NASH cirrhosis are similar to those with cirrhosis without NASH. However, NASH cirrhosis is associated with a higher 30-day mortality, predominantly from an increase in cardiovascular events and infections. Following liver transplant, there is a significant risk of NASH recurrence, although this seldom results in allograft loss. Furthermore, a significant number of patients who had a liver transplant for other reasons develop NASH de novo. When patients with NASH cirrhosis are considered for transplant, one of the major challenges lies in identifying which patients are too high risk for surgery. This review aims to provide information to aid this decision making process, and to provide guidance on the peri-operative care strategies that can modify risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“conventional (<10mmol/l) targets, for example in the NICE-SUGAR trial, moderately tight glycaemic control (6-10mmol/l) is recommended [109].”
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287 · cited 1×
“Longitudinal studies suggest that cardiovascular disease is the most common cause of death in NAFLD [19, 27-30]”
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907 · cited 1×
“For example, it is associated with endothelial dysfunction, increased carotid artery intima thickness, increased arterial stiffness and elevated coronary calcium scores, coronary artery disease (CAD), aortic valve sclerosis and cardiac arrhythmias, such as atrial fibrillation [16-21].”
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Evolving Frequency and Outcomes of Liver Transplantation Based on Etiology of Liver Disease
Singal, A. K., Guturu, P., Hmoud, B., Kuo, Y.-F., Salameh, H., & Wiesner, R. H. (2013) · Transplantation · doi:10.1097/tp.0b013e31827afb3a · Cited by 278 · cited 1×
“transplant, one year survival is 84-89%, three year survival is 78-85%, five year survival is 77-84%, and ten year survival is 84% [8, 122, 123].”
VanWagner, L. B., Bhave, M., Te, H. S., Feinglass, J., Alvarez, L., & Rinella, M. E. (2012) · Hepatology · doi:10.1002/hep.25855 · Cited by 220 · cited 1×
“In a study by Van Wagner et al, patients with NASH cirrhosis had a higher incidence of cardiovascular events compared to those with alcoholic cirrhosis in the first year post-transplant, (26% vs 8%), particularly in the first 30 days post-transplant [129].”
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation
Ravikumar, R., Tsochatzis, E., Jose, S., Allison, M., Athale, A., Creamer, F., Gunson, B., Iyer, V., Madanur, M., Manas, D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.005 · Cited by 173
Vallin, M., Guillaud, O., Boillot, O., Hervieu, V., Scoazec, J.-Y., & Dumortier, J. (2014) · Liver Transplantation · doi:10.1002/lt.23936 · Cited by 137
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting
Balitzer, D., Tsai, J.-H., & Gill, R. M. (2022) · Diagnostic Pathology · doi:10.1186/s13000-022-01247-y · Cited by 5
Filipovic, B. F., Latas, M., Kiurski, S., Al Kiswani, D., Filipovic, N., Marjanovic-Haljilji, M., Laketic, D., Aksic, M., Markovic, B., Kapor, S., et al. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3758 · Cited by 2
“NAFLD is the most frequent cause of liver disease in the Western world and among the leading causes of liver cirrhosis [1], hepatocellular carcinoma [2] and liver transplantation [3].”
Background
Metadata
- Authors
- Khan, R. S., & Newsome, P. N.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 65
- Issue
- 8
- Pages
- 1208-1223
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2292654144
- Cited by
- 50
- References
- 11
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-alcoholic fatty liver disease and liver transplantation. https://app.cochat.ai/papers/10.1016/j.metabol.2016.02.013
- The paper
- Khan, R. S., & Newsome, P. N. (2016). Non-alcoholic fatty liver disease and liver transplantation. Metabolism. https://doi.org/10.1016/j.metabol.2016.02.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.